Brainstorm Cell Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $511k | 1.5M | 0.34 |
| 2024-03-31 | $791k | 1.4M | 0.56 |
| 2023-12-31 | $389k | 1.4M | 0.27 |
| 2023-09-30 | $285k | 1.4M | 0.20 |
| 2023-06-30 | $2.9M | 1.4M | 2.06 |
| 2023-03-31 | $4.7M | 1.4M | 3.30 |
| 2022-12-31 | $2.3M | 1.4M | 1.64 |
| 2022-06-30 | $3.9M | 1.4M | 2.76 |
| 2022-03-31 | $4.8M | 1.4M | 3.36 |
| 2021-09-30 | $4.7M | 1.4M | 3.30 |
| 2021-06-30 | $5.5M | 1.4M | 3.86 |
| 2021-03-31 | $5.1M | 1.3M | 3.82 |
| 2020-12-31 | $5.9M | 1.3M | 4.53 |
| 2020-09-30 | $20M | 1.2M | 16.92 |
| 2020-06-30 | $15M | 1.4M | 11.21 |
| 2020-03-31 | $5.6M | 1.2M | 4.64 |
| 2019-12-31 | $3.3M | 772k | 4.28 |
| 2019-09-30 | $2.9M | 767k | 3.77 |
| 2019-03-31 | $3.0M | 692k | 4.28 |
| 2018-12-31 | $2.4M | 687k | 3.52 |
| 2018-09-30 | $2.6M | 694k | 3.77 |
| 2018-06-30 | $2.6M | 694k | 3.77 |
| 2018-03-31 | $2.2M | 680k | 3.27 |
| 2017-12-31 | $2.7M | 679k | 4.03 |
| 2017-09-30 | $2.8M | 678k | 4.10 |
| 2017-06-30 | $2.7M | 657k | 4.10 |
| 2017-03-31 | $2.7M | 639k | 4.23 |
| 2016-12-31 | $1.5M | 581k | 2.56 |
| 2016-09-30 | $1.4M | 571k | 2.44 |
| 2016-06-30 | $1.2M | 492k | 2.44 |
| 2015-12-31 | $1.3M | 463k | 2.82 |
| 2015-09-30 | $1.0M | 450k | 2.31 |
| 2015-06-30 | $1.5M | 418k | 3.59 |
| 2015-03-31 | $1.5M | 323k | 4.62 |